Peripheral Arterial Disease Clinical Trials in Gainesville, Florida

6 studies are recruiting for peripheral arterial disease in Gainesville, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. EVERO Drug-coated Balloon (DCB) Randomized Trial

   The primary objective of the study is to evaluate the long-term safety and effectiveness of the Advance Evero™ 18 Everolimus-coated Percutaneous Transluminal Angioplasty Balloon Catheter (hereafter referred to as the Evero drug-coated balloon [DCB]) in the treatment of the femoropopliteal artery le…

   Stage

   Not phased

   Ages

   18 and older

   Site

   The Cardiac and Vascular Institute, Gainesville, Florida

   Locations

   10 in total

   Run by

   Cook Research Incorporated

   See if you can join NCT07144150 on ClinicalTrials.gov

2. The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

   The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Florida - Gainesville, Gainesville, Florida

   Locations

   43 in total

   Run by

   W.L.Gore & Associates

   See if you can join NCT05811364 on ClinicalTrials.gov

3. SELUTION4BTK Trial

   This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.

   Stage

   Not phased

   Ages

   18 and older

   Site

   The Cardiac and Vascular Institute Research Foundation, Gainesville, Florida

   Locations

   48 in total

   Run by

   M.A. Med Alliance S.A.

   See if you can join NCT05055297 on ClinicalTrials.gov

4. PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

   A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

   Stage

   Not phased

   Ages

   18 to 95

   Site

   The Cardiac and Vascular Institute, Gainesville, Florida

   Locations

   30 in total

   Run by

   LimFlow, Inc.

   See if you can join NCT05313165 on ClinicalTrials.gov

5. Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

   The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular events in patients with symptomatic peripheral artery disease.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of Florida - Gainesville, Gainesville, Florida

   Locations

   70 in total

   Run by

   Population Health Research Institute

   See if you can join NCT04774159 on ClinicalTrials.gov

6. The ROAMM-EHR Study

   In recent years, mobile health (mHealth) apps have promised improved monitoring of health conditions to improve clinical outcomes. The objective of this study is to conduct a pilot randomized clinical trial (RCT) to evaluate the impact of using remotely collected patient generated health data (PGHD…

   Stage

   Not phased

   Ages

   60 to 100

   Site

   Institute of Aging, Gainesville, Florida

   Run by

   University of Florida

   See if you can join NCT06263322 on ClinicalTrials.gov